Classes & Events

The Center for Survivorship and Patient-Oriented Research and the Division of Hematologic Malignancies and Cellular Therapeutics will host a symposium on April 24 at the Sheraton Overland Park Hotel...

The Center for Survivorship and Patient-Oriented Research and the Division of Hematologic Malignancies and Cellular Therapeutics will host a symposium on April 24 at the Sheraton Overland Park Hotel...

Conference Objectives: 1. Analyze current CIBMTR and clinical trial data to inform evidence-based use of allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies. 2...

Series Objectives Review the results of studies in myeloproliferative diseases, multiple myeloma, leukemia, lymphoma, and CAR-T cell therapy from ASCO 2026 and ASH 2025 Discuss recent data on...